BioSpace News Archive

Quest Diagnostics, the world’s leading provider of diagnostic information services, announced that its Board of Directors declared a quarterly cash dividend of $0.56 per share, payable on February 3, 2021 to shareholders of record of Quest Diagnostics common stock on January 20, 2021.

For the past 20 years, global healthcare manufacturer’s HALYARD-branded product line of masks and N95 respirators has ranked at the top of the facial protection market

Caraway Therapeutics today announced that the Company has been awarded a second research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF)

Today, the Los Angeles Network for Enhanced Services (LANES) and The Los Angeles County Department of Health Services (DHS) announced their co-partnership with Fulgent Genetics Inc. (NASDAQ:FLGT) to support the data exchange of coronavirus tests performed at nearly 20 local drive-thru, walk-up and community clinic testing sites.

Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., announced two recent online publications of studies related to the efficacy, safety and pharmacokinetics of Adhansia XR® (methylphenidate hydrochloride) extended-release capsules CII (investigationally known as PRC-063).

Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from the Phase 2/3 CAPELLA trial evaluating the company’s investigational, long-acting HIV-1 capsid inhibitor, lenacapavir, in heavily treatment-experienced people with multidrug resistant HIV-1 infection.

Todos Medical (OTCQB: TOMDF) , an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for early detection of cancer and Alzheimer’s disease, today announced positive clinical proof of concept data from its lab-based rapid SARS-CoV-2 3CL protease diagnostic assay in collaboration with its COVID Antigen Te

Enosi Life Sciences Corp. (“Enosi” or the “Company”), a drug research and development company focused on providing industry-leading therapeutics for autoimmune disease, cancer, and acute inflammation, today announced it has filed a patent for its proprietary molecules

Embracing Carers™, a global initiative led by EMD Serono, raises awareness about the often-overlooked needs of unpaid caregivers and develops solutions collaboratively with global caregiving organizations.

Associate Professor Amir Talaei-Khoei at University of Nevada, Reno believes SARS-COV-2 has motivated scientific community to battle the enhancing pandemic using interdisciplinary effort.